麦少珍

    【摘要】 目的：探讨米氮平联合氟哌噻吨美利曲辛对双相情感障碍(BPD)的治疗效果。方法：选取2019年7月-2020年7月本院收治的60例BPD患者，按随机数字表法将其分为对照组与观察组，每组30例。对照组应用米氮平治疗，观察组应用米氮平联合氟哌噻吨美利曲辛治疗，两组均治疗4周。比较两组临床疗效、贝克-拉范森躁狂量表(Bech-Rafaelsdn mania rating scale，BRMS)、汉密尔顿抑郁量表(HAMD)、生活质量综合评定量表(GQOLI-74)评分及不良反应发生情况。结果：观察组治疗总有效率为93.33%，高于对照组的70.00%(P0.05)。结论：米氮平联合氟哌噻吨美利曲辛可有效改善BPD患者的临床症状，提高生活质量，疗效较好，值得临床借鉴。

    【关键词】 米氮平 氟哌噻吨美利曲辛 双相情感障碍

    [Abstract] Objective： To investigate the efficacy of Mirtazapine combined with Flupentixol and Melitracen in the treatment of bipolar disorder (BPD). Method： A total of 60 patients with BPD in our hospital from July 2019 to July 2020 were selected. They were divided into control group and observation group according to random number table method， 30 cases in each group. The control group was treated with Mirtazapine ......